YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOGICAL PHARMACEUTICAL CO LTD
Overview
YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOGICAL PHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 27 active FDA Type II Drug Master Files, covering AFATINIB DIMALEATE NON-STERILE DRUG SUBSTANCE; ARIPIPRAZOLE NON-STERILE DRUG SUBSTANCE; DEXMEDETOMIDINE HYDROCHLORIDE NON-STERILE DRUG SUBSTANCE; DEXRAZOXANE NON-STERILE DRUG SUBSTANCE; DIQUAFOSOL SODIUM NON-STERILE DRUG SUBSTANCE; DOXOFYLLINE NON-STERILE DRUG SUBSTANCE.
Core services & business areas
Active pharmaceutical ingredients supplied
Substances YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOGICAL PHARMACEUTICAL CO LTD is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOGICAL PHARMACEUTICAL CO LTD holds 32 active (32 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- ANASTROZOLE NON-STERILE DRUG SUBSTANCEActive2026-06-28
- POMALIDOMIDE NON-STERILE DRUG SUBSTANCEActive2026-06-10
- NALBUPHINE HYDROCHLORIDE NON-STERILE DRUG SUBSTANCEActive2026-05-13
- POSACONAZOLE NON-STERILE DRUG SUBSTANCEActive2026-04-21
- GADOPICLENOL SM1Active2026-04-07
- LEVOSIMENDAN NON-STERILE DRUG SUBSTANCEActive2026-03-31
- ARIPIPRAZOLE NON-STERILE DRUG SUBSTANCEActive2026-03-17
- LENVATINIB MESILATE NON-STERILE DRUG SUBSTANCEActive2026-03-17
- SODIUM PICOSULFATE NON-STERILE DRUG SUBSTANCEActive2025-11-26
- AFATINIB DIMALEATE NON-STERILE DRUG SUBSTANCEActive2025-10-22
- SUGAMMADEX SODIUM NON-STERILE DRUG SUBSTANCEActive2025-09-17
- DEXRAZOXANE NON-STERILE DRUG SUBSTANCEActive2025-08-15
- SITAFLOXACIN NON-STERILE DRUG SUBSTANCEActive2025-07-07
- LINAGLIPTIN NON-STERILE DRUG SUBSTANCEActive2025-05-29
- DOXOFYLLINE NON-STERILE DRUG SUBSTANCEActive2025-04-10
Showing 15 of 32 Drug Master Files.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOGICAL PHARMACEUTICAL CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOGICAL PHARMACEUTICAL CO LTD? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.